Communiqués Silk Road Medical, Inc

Actions

SILK

US82710M1009

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 31/05/2024			Varia. 5j.	Varia. 1 janv.
21,74 ^USD	+5,64 %		-0,87 %	+77,18 %

15/05	Transcript : Silk Road Medical, Inc Presents at Bank of America Health Care Conference 2024, May-14-2024 through May-16-2024
30/04	Transcript : Silk Road Medical, Inc, Q1 2024 Earnings Call, Apr 30, 2024

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Silk Road Medical: Q1 Earnings Snapshot	30/04	AQ
Silk Road Medical Reports First Quarter 2024 Financial Results	30/04	GL
Silk Road Medical to Present at the BofA Securities 2024 Healthcare Conference	23/04	GL
Silk Road Medical to Report First Quarter 2024 Financial Results on April 30, 2024	09/04	GL
Silk Road Medical Strengthens TCAR Portfolio with Launch of ENROUTE Transcarotid Neuroprotection System PLUS	02/04	GL
Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System	05/03	GL
Silk Road Medical Expands TCAR® Portfolio with Launch of Tapered ENROUTE® Transcarotid Stent System	05/03	AQ
Silk Road Medical: Q4 Earnings Snapshot	28/02	AQ
Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook	28/02	GL
Silk Road Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Financial Outlook	28/02	AQ
Silk Road Medical to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	07/02	GL
Silk Road Medical to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024	07/02	AQ
Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference	20/12	GL
Silk Road Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference	20/12	AQ
Silk Road Medical: Q3 Earnings Snapshot	08/11	AQ
Silk Road Medical Reports Third Quarter 2023 Financial Results	08/11	GL
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Silk Road Medical, Inc. - SILK	03/11	PR
Silk Road Medical Names Chas McKhann Chief Executive Officer	02/11	GL
Silk Road Medical Names Chas McKhann Chief Executive Officer	02/11	AQ
Silk Road Medical to Report Third Quarter 2023 Financial Results on November 8, 2023	26/10/23	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Silk Road Medical, Inc

Actions

SILK

US82710M1009

Communiqués

Filtres